Key Insights

Highlights

Treatment Research

2 treatments under study, led by Apiretal 100 Mgml Solución Oral

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
SYFf02ff33946e54b8694b900cbcfc48b37Phase 1Unknown

A single dose, randomized, open-label, three-way crossover study to assess bioequivalence of paracetamol orodispersible tablets 500 mg vs Apiretal® 100 mg/ml oral solution in healthy volunteers under fasting conditions

Showing all 1 trials

Research Network

Common Treatments

  • Apiretal 100 Mgml Solución Oral1
  • Apiretal 500 Mg Comprimidos Bucodispersables1

Active Sponsors

  • Laboratorios Ern S.A.1

Activity Timeline